Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,261,602
-$1,057,159 QoQ
Shares Held
8,905
-34.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#2,244
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Plante Moran Financial Advisors, LLC holds $5,321,402 across 15 Drug Manufacturers - General names. JNJ ranks #1 (42.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
8,905 | $2,261,602 | |
| 2 | LLY |
ELI LILLY & Co
|
839 | $1,006,321 | |
| 3 | AMGN |
Amgen Inc
|
2,109 | $763,711 | |
| 4 | ABBV |
AbbVie Inc.
|
2,355 | $592,612 | |
| 5 | PFE |
Pfizer Inc
|
11,175 | $269,094 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,290 | $165,765 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,848 | $106,481 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
677 | $85,532 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,261,602 | 8,905 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,318,761 | 13,577 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,286,159 | 15,879 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,044,040 | 16,417 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,519,404 | 9,947 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,964,208 | 11,844 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,154,548 | 14,898 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,682,741 | 16,554 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,257,879 | 15,448 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,171,632 | 13,728 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,042,008 | 13,028 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,052,162 | 13,176 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,214,823 | 13,381 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,921,070 | 12,394 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,271,012 | 12,856 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,099,502 | 12,852 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $2,329,996 | 13,126 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,569,371 | 8,855 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,626,875 | 9,510 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,543,778 | 9,559 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,489,084 | 9,039 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,342,082 | 8,166 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,321,834 | 8,399 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,770,480 | 11,892 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,893,723 | 13,466 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,857,456 | 14,165 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||